Exelixis
EXEL
#1556
Rank
A$19.90 B
Marketcap
A$80.34
Share price
-1.95%
Change (1 day)
34.01%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company